Vadim Backman, Co-Founder, CTO & Chairman
Vadim Backman is a professor of Biomedical Engineering and the director of the Biophotonics Center at Northwestern University, as well as a Member of Professional Staff at Evanston-Northwestern Healthcare. He is a co-founder, Chairman, and Chief Technology Officer at American BioOptics LLC.
Professor Backman received his Ph.D. degree from the MIT and Harvard University Division of Health Sciences and Technologies. His research focuses on the development of novel optical technologies for biomedical applications.
Professor Backman has received a number of prestigious awards, including the NSF CAREER award and the General Motors Cancer Research Scholar Award. He was also selected by MIT’s Technology Review magazine as one of the top 100 young innovators in the world. Professor Backman has published more than 70 peer-reviewed publications in leading scientific journals including Nature, Nature Medicine, PNAS, Physical Review, Gastroenterology, and Optics Letters.
Andrew Cittadine, Co-Founder
Mr. Cittadine is a successful technology entrepreneur with ten years experience in general management and senior marketing roles. He is a co-founder of American BioOptics LLC.
Until February 2007, Mr. Cittadine served as the interim CEO for SonarMed, a development stage, venture-backed medical device company in Indianapolis. Prior to SonarMed, he was a co-founder of Sensant Corporation, a Silicon Valley medical imaging company providing diagnostic quality 3D ultrasound imaging. Mr. Cittadine helped lead the company through a successful acquisition by Siemens in June 2005. Prior to that, he held positions in semiconductor design and manufacturing at Motorola.
Mr. Cittadine holds a BS and MS in Electrical Engineering from Stanford where he was elected to Tau Beta Pi. He received an MBA with distinction from the Kellogg School of Management at Northwestern University.
Michael Goldberg MD, Director of Clinical Relations and Co-Founder
Dr. Goldberg is a practicing gastroenterologist, an associate professor at the Feinberg School of Medicine at Northwestern University, and the section chief of gastroenterology at Evanston Northwestern Healthcare. He is Director of Clinical Relations at American BioOptics LLC.
Dr. Goldberg graduated with high honors from both the University of Illinois and the University of Illinois medical school. He was chief medical resident at the Westside Veteran’s Administration in Chicago and completed his GI fellowship at Tufts New England Medical Center in Boston. Dr. Goldberg has previously held academic appointments at the University of Illinois and the University of Chicago. He is a past president of the Chicago Society of Endoscopy, the Chicago GI Society, and a former Governor of Illinois for the American College of Physicians. Dr. Goldberg has been named as one of Chicago’s best doctors and has received numerous citations as one of the best doctors in the U.S. In the 90s he was part of the team that successfully lobbied Congress for the Colorectal Cancer Screening Bill.
Hemant K. Roy, MD, Co-Founder and Director of Clinical Research
Dr. Roy is a clinical gastroenterologist, as well as director of gastroenterology research at Evanston-Northwestern Healthcare, co-leader of the Gastrointestinal Oncology Working Group at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, and an Associate Professor of Medicine at Northwestern’s Feinberg School of Medicine. Dr. Roy is a co-founder and Director of Clinical Research at American BioOptics LLC.
Dr. Roy received his bachelor’s degree in Molecular Biology at Vanderbilt University and graduated with distinction from Northwestern University Medical School. He continued his internal medicine training at Harvard University and took his gastroenterology fellowship at the University of Chicago.
Dr. Roy has co-authored more than 40 peer reviewed publications. His expertise in clinical research is underscored by his selection as a Deputy Editor for the Archives of Internal Medicine. Dr. Roy has received numerous awards including career development awards through the American Society of Clinical Oncology and Glaxo Institute of Digestive Health. In addition, he is a primary member and a funded principal investigator of the National Cancer Institute’s Early Detection Research Network (EDRN).